Sustaining Cancer Research and Oncology: A Call to Congress

23 Visioni
Published
In this month's Chief Insights in Oncology, Robert L. Ferris, UNC Lineberger Comprehensive Cancer Center and editor-in-chief of Targeted Therapies in Oncology, discusses his August column.

Read Ferris's full column from this month: https://www.targetedonc.com/view/approaching-a-critical-juncture-to-preserve-the-oncology-enterprise

Ferris, with 25 years of experience in the field, notes that while financial pressures have always existed, he has "cannot recall a period during which this immensely productive clinical oncology and research enterprise faced simultaneous threats to its foundation, as we have observed in the past 4 months." These threats are multifaceted, impacting both research funding and clinical care delivery.

For more resources and information regarding anticancer targeted therapies: http://targetedonc.com/
Categoria
Oncology
Commenta per primo questo video.